ABBV — AbbVie Inc. stock price and chart

ABBV

AbbVie Inc.Stock · HealthcareS&P 500 0.7% · Russell 1000 0.6% · US Stock Market 0.6% · Russell 3000 0.6% · MSCI World 0.4% · MSCI ACWI 0.4% · S&P 500 Equal Weight 0.2%

$257.12+0.83%

as of market close, Sep 11, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKAMGN

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

60.080.0100.0120.0140.0160.0180.0200.0220.0240.0260.00100.0M$257.12

2026-09-11

Price$257.12

MA20$232.92

MA50$224.25

Vol25.7M

What would $1,000 invested in ABBV be worth today? →

ABBV returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $257.12
Change YTD: +15.19%
Next earnings: Oct 30, 2026
Market cap: 454.4B2016-09 102.5B2026-09 454.4B+343.3% over the window
Enterprise value: 511.2B
Shares outstanding: 1.8B2016-06 1.6B2026-06 1.8B+8.5% over the window
52W low: $190.75
52W high: $267.47
From 52W high: -3.87%
From 52W low: +34.79%
52W range: 87%
Beta: 0.29

Volume

Rel volume: 0.92×
30D volume: 4.7M
30D $ vol: 1.2B

Fundamentals

Sales (ttm): 64.4B2016-06 24.8B2026-06 64.4B+160.1% over the window
Sales/share: $36.442016-06 $15.202026-06 $36.44+139.7% over the window
EPS (ttm): $3.542016-06 $3.472026-06 $3.54+2.0% over the window
FCF (ttm): 18.2B2016-06 7.6B2026-06 18.2B+138.4% over the window
FCF/share: $10.302016-06 $4.692026-06 $10.30+119.7% over the window
Book value/share: -$3.362016-06 $3.462026-06 -$3.36-197.0% over the window
Net margin: 9.80%2016-06 23.1%2026-06 9.8%-57.6% over the window
ROA: 4.67%2016-06 8.5%2026-06 4.7%-45.1% over the window
Current ratio: 0.812016-06 1.812026-06 0.81-55.4% over the window

Growth (CAGR, ttm) · 10Y

Sales: +10.39%2025-06-30 → 2026-06-3058.3B → 64.4B (+10.4% total)+4.75%2023-06-30 → 2026-06-3056B → 64.4B (+14.9% total)+3.69%2021-06-30 → 2026-06-3053.7B → 64.4B (+19.8% total)+10.03%2016-06-30 → 2026-06-3024.8B → 64.4B (+160.1% total)
Net income: +67.74%2025-06-30 → 2026-06-303.8B → 6.3B (+67.7% total)-10.10%2023-06-30 → 2026-06-308.7B → 6.3B (-27.3% total)-1.08%2021-06-30 → 2026-06-306.7B → 6.3B (-5.3% total)+0.99%2016-06-30 → 2026-06-305.7B → 6.3B (+10.3% total)
FCF: -0.16%2025-06-30 → 2026-06-3018.2B → 18.2B (-0.2% total)-9.78%2023-06-30 → 2026-06-3024.8B → 18.2B (-26.6% total)-1.43%2021-06-30 → 2026-06-3019.6B → 18.2B (-7.0% total)+9.08%2016-06-30 → 2026-06-307.6B → 18.2B (+138.4% total)
Shares: +0.03%2025-06-30 → 2026-06-301.8B → 1.8B (+0.0% total)+0.04%2023-06-30 → 2026-06-301.8B → 1.8B (+0.1% total)-0.00%2021-06-30 → 2026-06-301.8B → 1.8B (-0.0% total)+0.82%2016-06-30 → 2026-06-301.6B → 1.8B (+8.5% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +68.63%2025-06-30 → 2026-06-30$2.10 → $3.54 (+68.6% total)-10.02%2023-06-30 → 2026-06-30$4.86 → $3.54 (-27.2% total)-0.93%2021-06-30 → 2026-06-30$3.71 → $3.54 (-4.6% total)+0.20%2016-06-30 → 2026-06-30$3.47 → $3.54 (+2.0% total)
Sales/share: +10.36%2025-06-30 → 2026-06-30$33.02 → $36.44 (+10.4% total)+4.70%2023-06-30 → 2026-06-30$31.74 → $36.44 (+14.8% total)+3.69%2021-06-30 → 2026-06-30$30.40 → $36.44 (+19.8% total)+9.14%2016-06-30 → 2026-06-30$15.20 → $36.44 (+139.7% total)
FCF/share: -0.19%2025-06-30 → 2026-06-30$10.32 → $10.30 (-0.2% total)-9.82%2023-06-30 → 2026-06-30$14.05 → $10.30 (-26.7% total)-1.43%2021-06-30 → 2026-06-30$11.08 → $10.30 (-7.0% total)+8.19%2016-06-30 → 2026-06-30$4.69 → $10.30 (+119.7% total)
Dividend/share: +5.57%2025-06-30 → 2026-06-30$6.47 → $6.83 (+5.6% total)+5.30%2023-06-30 → 2026-06-30$5.85 → $6.83 (+16.8% total)+6.44%2021-06-30 → 2026-06-30$5.00 → $6.83 (+36.6% total)+11.90%2016-06-30 → 2026-06-30$2.22 → $6.83 (+207.7% total)
Price: +16.77%2025-09-11 → 2026-09-11$220.22 → $257.12 (+16.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+19.93%2023-09-11 → 2026-09-11$149.04 → $257.12 (+72.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+19.23%2021-09-10 → 2026-09-11$106.68 → $257.12 (+141.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.03%2016-09-09 → 2026-09-11$63.36 → $257.12 (+305.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +20.39%2025-09-11 → 2026-09-11$213.59 → $257.12 (+20.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+24.14%2023-09-11 → 2026-09-11$134.37 → $257.12 (+91.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+23.68%2021-09-10 → 2026-09-11$88.79 → $257.12 (+189.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+19.85%2016-09-09 → 2026-09-11$42.03 → $257.12 (+511.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 72.6×2016-09 16.862026-09 72.01+327.1% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 26.9×2016-09 11.222026-09 26.93+140.2% over the window
Fwd P/E: 15.3×
P/S (ttm)Market cap ÷ TTM revenue.: 7.1×2016-09 4.062026-09 7.06+73.8% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: -76.6×2016-09 15.842026-09 -76.56-583.2% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 25.0×2016-09 14.742026-09 24.95+69.3% over the window
EV/EBITDA (fy): 20.6×
EV/Sales (ttm): 7.9×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 4.01%2016-06 7.5%2026-06 4.1%-45.2% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 2.66%
Dividend/share (fwd): $6.83
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 1.77B ÷ 1.77B. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -0.03%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-0.03%) + dividends paid over that year ($12B) ÷ market_cap_at(2025-06-30) ($327.9B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 3.62%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($1.5B) ÷ today's market cap ($454.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.33%2016-06 6.3%2026-06 0.3%-94.6% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $1.5B + TTM dividends $12B) ÷ today's market cap ($454.4B). Same caveat as the cash buyback yield.: 2.97%2016-06 9.8%2026-06 3.0%-69.0% over the window

Vs own 10Y history

P/E: 85th
P/OI: 87th
P/S: 99th
P/B: 97th
P/FCF: 99th

Bar = where today’s multiple sits in ABBV’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · windows as of 2026-09-11

+0.83%

-1.19%

+3.36%

+15.21%

YTD

+15.19%

+25.26%

+175.77%

Financial statements

Open full ABBV financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-8.44%	-0.65%
JNJ	Johnson & Johnson	+2.31%	-0.29%
MRK	Merck & Co. Inc.	+8.28%	-0.54%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-6.53%	-2.37%
TMO	Thermo Fisher Scientific Inc.	+1.13%	+1.10%
AMGN	Amgen Inc.	-8.80%	-1.34%
GILD	Gilead Sciences Inc.	+5.78%	-0.75%
ABT	Abbott Laboratories	-8.08%	-1.36%

AbbVie Inc. (ABBV) trades at $257.12 with a live price and an interactive chart covering 13+ years of daily price history, plus key valuation metrics. ChartRow also publishes ABBV’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ABBV financial statements →

ABBV — AbbVie Inc. price, chart and key statistics